Peptide therapy TikTok claims: what the science actually supports

What did @justagrownwoman actually say?

The creator is starting GHK-Cu, a copper-binding peptide, and wants to minimize injection site burning. She calls it "Botox in the bottle" and "the anti-aging peptide," listing benefits including reduced inflammation, acne, scarring, stretch mark lightening, hair growth extension, and even gray hair reversal. She's working with a 100mg vial, planning to reconstitute with around 3mL of bacteriostatic water, then add an additional 20 units of diluent to reduce the sting. She says she'll inject subcutaneously into the abdomen based on community reports of fewer side effects there.

That's a lot of claims packed into one video. Some are grounded in real research. Some are extrapolations from cell studies that have never been tested in humans at scale. And at least one, the gray hair reversal claim, is essentially social media folklore at this point.

Does the science back this up?

Partially, and the gap between the lab evidence and the TikTok pitch is significant. GHK-Cu (glycyl-L-histidyl-L-lysine copper) has a genuine research base, but almost none of it comes from controlled human trials.

The peptide was first isolated by Loren Pickart in the 1970s and has been studied for wound healing, skin remodeling, and anti-inflammatory effects primarily in vitro and in animal models. Pickart et al. (2015, Journal of Aging Research) summarized decades of work showing GHK-Cu stimulates collagen synthesis, promotes antioxidant activity, and modulates gene expression in skin fibroblasts. That's real. But "modulates fibroblast gene expression in a dish" is not the same as "Botox in a bottle."

Hair growth? There's more here than you'd expect. Uno et al. (1985, Journal of Investigative Dermatology) showed copper peptides could extend the anagen phase in animal models. A more recent review by Rajput (2018, Journal of Cosmetics, Dermatological Sciences and Applications) supports topical GHK-Cu as a legitimate hair follicle stimulant. The mechanism, prolonging the growth cycle, is exactly what the creator describes. Credit where it's due.

Gray hair reversal? No credible human data supports this. None.

What did they get wrong (or right)?

Let's be direct about what holds up and what doesn't.

The burn issue is real and her instinct to dilute aggressively is reasonable. The copper component can cause localized irritation, particularly at higher concentrations. Injecting into subcutaneous abdominal tissue, which has more fat padding than the deltoid or thigh, does reduce sting for many peptides. The community experience she's referencing is consistent with what's reported in peptide user forums and some clinical compounding notes. She's not wrong here.

The "stretch marks lighten" claim is plausible but unproven in humans via injection. Topical GHK-Cu has some evidence for improving skin texture (Finkley et al., 2007, Journal of Cosmetic Dermatology), but injecting it systemically for stretch mark lightening is a different mechanism claim that has zero clinical trial support.

"Botox in a bottle" is marketing language, not science. Botulinum toxin works by blocking neuromuscular junctions. GHK-Cu works through collagen stimulation and antioxidant pathways. These are completely different mechanisms producing superficially similar aesthetic outcomes in some users. Calling them equivalent is misleading.

The gray hair reversal claim is where the video loses the most credibility. The creator even hedges with "I saw some video where it said," which is not a citation. There is no peer-reviewed evidence that GHK-Cu reverses melanocyte activity or restores pigment production in humans.

What should you actually know?

GHK-Cu is one of the more researched peptides in the cosmetic and regenerative space, but "more researched than most peptides" is a low bar. It is not FDA-approved for systemic injection. In the US, it exists in a regulatory gray area as a compounded or research peptide, and quality control between suppliers varies considerably.

The reconstitution math she's working through matters more than most viewers probably realize. A 100mg vial reconstituted in 3mL gives you roughly 33mg per mL. If you're dosing subcutaneously, knowing exactly what concentration you're injecting is not optional. Getting this wrong in either direction, too concentrated or too dilute, affects both efficacy and injection site reactions.

Anyone considering GHK-Cu should know: the topical evidence is more robust than the injectable evidence for cosmetic outcomes. The anti-inflammatory and wound healing data are the strongest parts of its research profile. The beauty claims are the weakest. And "I heard a lot of reports" is not a dosing or efficacy guide.

Work with a provider who can order from a licensed compounding pharmacy, verify peptide purity, and help you understand what you're actually injecting and why.